Effect of Moringa Oleifera Leaf on Hemoglobin Levels in Anemia

Study Overview
=================
Brief Summary
-----------------
The main objective of this study was to compare the results of hemoglobin levels between pregnant women in the treatment group and the control group. Participants will be subjected to anthropometric measurements, recall of food intake for 1 x 24 hours, check hemoglobin before and after being given the intervention and participants in the treatment group are given moringa leaf capsules and iron tablets while participants in the control group are only given iron tablets. Researchers will compare the final results of hemoglobin levels between the treatment group and the control group

Official Title
-----------------
Effect of Moringa Oleifera Leaf Capsul on Hemoglobin Levels in Anemia: A Pilot Study

Conditions
-----------------
Anemia of Pregnancy

Intervention / Treatment
-----------------
* Dietary Supplement: Moringa oleifera capsules
* Dietary Supplement: iron and folic acid supplements


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Pregnant women with 2nd and 3rd trimester of pregnancy Pregnant women with mild to moderate anemia At day 90 after treatment Exclusion Criteria : Hypotensive pregnant women Pregnant women with Gemelli Pregnant women with chronic diseases (hepatitis and HIV)

Ages Eligible for Study
-----------------
Minimum Age: 15 Years
Maximum Age: 50 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: 1 group receives capsules of powdered Moringa leaves (active comparator), and the other group receives IFA tablets as part of routine clinical care.
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Moringa oleifera leaf capsule<br>Subjects in this arm receive experimental capsules containing powdered Moringa oleifera leaf capsules along with IFA tablets | Dietary Supplement: Moringa oleifera capsules<br>* In this arm, pregnant mothers receive capsules containing 500 mg of powdered Moringa oleifera leaves which contain 13.09 mg of iron per100 gram. Dose: 2 × 2 capsules per day for 30 days<br>Dietary Supplement: iron and folic acid supplements<br>* In this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate.<br>|
| Active Comparator: Iron and folic acid capsule<br>Subjects in this arm only receive iron and folic acid (IFA) tablets | Dietary Supplement: iron and folic acid supplements<br>* In this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Changes in Haemoglobin (Hb) level | Hb will be meassured twice, before treatment and 30 days after treatment | Day 0 and day 30 |